These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1782067)

  • 1. Early cardiac toxicity of 4'-iodo-4'-deoxydoxorubicin.
    Villani F; Galimberti M; Comazzi R
    Eur J Cancer; 1991; 27(12):1601-4. PubMed ID: 1782067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.
    Ringenberg QS; Propert KJ; Muss HB; Weiss RB; Schilsky RL; Modeas C; Perry MC; Norton L; Green M
    Invest New Drugs; 1990 May; 8(2):221-6. PubMed ID: 2166722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study with 4'-deoxydoxorubicin.
    Ferrari L; Rossi A; Brambilla C; Bonfante V; Villani F; Crippa F; Bonadonna G
    Invest New Drugs; 1984; 2(3):287-95. PubMed ID: 6511235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans.
    Robert J; Armand JP; Huet S; Klink-Alakl M; Recondo G; Hurteloup P
    J Clin Oncol; 1992 Jul; 10(7):1183-90. PubMed ID: 1607922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paucity of chronic electrocardiographic changes with adriamycin therapy.
    Weaver SK; Fulkerson PK; Lewis RP; Leier CV
    J Electrocardiol; 1978 Jul; 11(3):233-8. PubMed ID: 690550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumors.
    Pratt CB; Douglass EC; Meyer WH; Hayes FA; Horowitz ME; Thompson EI; Avery L
    Invest New Drugs; 1989 Jul; 7(2-3):209-11. PubMed ID: 2793374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac arrhythmias in patients with small cell lung cancer and cardiac disease before, during and after doxorubicin administration. An evaluation of acute cardiotoxicity by continuous 24-hour Holter monitoring.
    Raabe NK; Storstein L
    Acta Oncol; 1991; 30(7):843-6. PubMed ID: 1662523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute arrhythmogenicity of doxorubicin administration.
    Steinberg JS; Cohen AJ; Wasserman AG; Cohen P; Ross AM
    Cancer; 1987 Sep; 60(6):1213-8. PubMed ID: 3621107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the cardiotoxic effects of antineoplastic antibiotics adriamycin and pharmorubicin].
    Valvere VIu; Shkhvatsabaia LV; Niu-Tian-de GB
    Kardiologiia; 1989 Sep; 29(9):64-7. PubMed ID: 2687558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogs.
    Monti E; Piccinini F; Favalli L; Villani F
    Biochem Pharmacol; 1983 Nov; 32(22):3303-6. PubMed ID: 6580906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ECG changes in adriamycin therapy].
    Pötzi P; Huber J; Kühböck J; Weber H
    Acta Med Austriaca Suppl; 1979; 6():339-41. PubMed ID: 299225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.
    Leitner SP; Casper ES; Hakes TB; Kaufman RJ; Winn RJ; Scoppetuolo M; Raymond V; Geller NL; Young CW
    Cancer Treat Rep; 1985 Nov; 69(11):1319-20. PubMed ID: 4092194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines].
    Pisacane C; Iarussi D; Buono S; Gualtieri S; Coppolino P; Iacono A
    G Ital Cardiol; 1991 Dec; 21(12):1259-67. PubMed ID: 1818000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic evaluation of adriamycin cardiotoxicity in children.
    Ramos A; Meyer RA; Korfhagen J; Wong KY; Kaplan S
    Cancer Treat Rep; 1976 Sep; 60(9):1281-4. PubMed ID: 1016964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
    Platel D; Bonoron-Adèle S; Dix RK; Robert J
    Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia potentiates doxorubicin-related cardiotoxic effects.
    Kim YD; Lees DE; Lake CR; Whang-Peng J; Schuette W; Smith R; Bull J
    JAMA; 1979 Apr; 241(17):1816-7. PubMed ID: 430749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.